澄清各种Helicobacter pylori根除疗法:一个全面的审查
Xiaoqi Wu1,2, Miao Duan1,2, Qingzhou Kong1,2
1Department of Gastroenterology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Helicobacter
|May 8, 2024
概括
标准化Helicobacter pylori (H. pylori) 根除是至关重要的. 在有可用数据的地区,为期10天的木四倍疗法 (BQT) 是首选的选择,强调量身定制的治疗持续时间和患者教育,以有效去除H. pylori.
科学领域:
- 胃肠病学 胃肠病学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 在目前的Helicobacter pylori (H. pylori) 根除策略中存在全球变异.
- 主要的疗法包括三重疗法 (TT),比斯四重疗法 (BQT) 和高剂量双重疗法 (HDDT).
- 治疗方案在持续时间,敏感性测试,酸抑制剂使用和患者教育方面有所不同.
研究的目的:
- 进行对H. pylori根除方案的系统文献审查.
- 为消除H. pylori提供标准化的治疗建议.
- 减少来自不同根除方案的结合发现的风险.
主要方法:
- 关于H. pylori治疗方案的综合系统文献综述.
- 对治疗持续时间,敏感性测试,酸抑制剂使用和患者教育的分析.
- 评估区域研究证据和抗生素耐药性模式.
主要成果:
- 建议的最佳持续时间:TT为14天,BQT为10天,HDDT为14天 (区域依赖).
- 敏感性测试对于TT至关重要;根据当地因素,对于BQT是可选的.
- 酸抑制剂的选择和患者的教育显著影响治疗方案的疗效.
结论:
- 在有本地研究证据的地区,可能更喜欢10天的经验BQT疗法.
- 调整治疗持续时间,在适当的情况下进行敏感性测试,并优化酸抑制剂的使用是关键.
- 有效的患者教育对于成功根除H. pylori至关重要.
相关概念视频
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
371
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
371
01:26Peptic Ulcer Disease IV: Management
89
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
89
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
113
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
113
01:13Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
380
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
380
01:23Gastritis III: Clinical Manifestations and Management
228
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
228
01:28Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
428
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
428